lanthanum carbonate

FDA Drug Profile — Fosrenol

Drug Details

Generic Name
lanthanum carbonate
Brand Names
Fosrenol
Application Number
NDA204734
Sponsor
Takeda Pharmaceuticals America, Inc.
NDC Codes
5
Dosage Forms
POWDER, TABLET, CHEWABLE
Routes
ORAL
Active Ingredients
LANTHANUM CARBONATE

Indications and Usage

1 INDICATIONS AND USAGE FOSRENOL ® is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). Management of elevated serum phosphorus levels in patients with ESRD usually includes all of the following: reduction in dietary intake of phosphate, removal of phosphate by dialysis, and reduction of intestinal phosphate absorption with phosphate binders. FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). ( 1 )